However, for ESAT-6, which is an antigen included in commercial IFN-gamma release assays to assess TB infection [26], such improvement of the immune response was not achieved, suggesting that this antigen, at least in our experience, does not seem to be adequate to evaluate the immune response in severely immunosuppressed TB-HIV patients. Here, IFNG is linked to tuberculosis.